Tag: FDA findings

Deficiency Letters in Generic Drug Applications: Common FDA Findings and How to Avoid Them

by Arnold Kendrick

Learn the most common FDA deficiency letter findings in generic drug applications and how to avoid them. Get data-backed insights on dissolution, impurities, manufacturing, and bioequivalence issues that delay approval.

Recent-posts

Thalidomide and Teratogenic Medications: History and Lessons

Mar, 30 2026

IBS-Mixed: How to Manage Alternating Constipation and Diarrhea

Jan, 3 2026

Batch Variability and Bioequivalence: What the Acceptable Limits Really Mean

Feb, 2 2026

Closed-Loop Systems: Automated Insulin Delivery and Real-World Results

May, 7 2026

anabolicsfast.lt Online Pharmacy: Is It Legit, Safe, and Legal in Australia (2025)

Aug, 26 2025